Research protocols and doses used with SS-31 peptide
Research protocols and doses used with SS-31 peptide The study of the SS-31 peptide (Elamipretida) is in a very interesting transition phase: while in the hospital clinical environment the protocols are rigid and well documented, in the community of longevity medicine and optimization (biohacking), the guidelines vary considerably. […]